Literature DB >> 2245163

Effect of tumour necrosis factor and lipid A on functional and structural vascular volume in solid murine tumours.

P A van de Weil1, G J Bouma, A van der Pijl, E S Weitenberg, A W Lam, N Bloksma.   

Abstract

Effects of recombinant tumour necrosis factor (TNF) on functional and structural vascular volumes in solid murine Meth A tumours were investigated by injection of Hoechst 33342 and staining for the vascular basement membrane component laminin, respectively. Systemic injection of 3 x 10(4) U TNF caused an initial increase in functional volume in the tumour, but a strong decrease from 1 to 48 h after treatment. Early effects of intralesional treatment were more moderate. Systemic injection of 10(4) U TNF or 0.3 or 3 micrograms lipid A caused a fall in functional volume at 4 h, but a recovery was seen at 24 h. This recovery did not occur after treatment with a combination of 10(4) U TNF and 0.3 micrograms lipid A. Structural vascular volume was not markedly reduced until 24 h after treatment with the high doses of the separate agents and the combination. All effects appeared generally more prominent in the tumour centre than in the borders. Data suggest that TNF induces initially an active hyperaemia that rapidly converts to passive hyperaemia. A prolonged disturbance of tumour blood supply is probably necessary for therapeutic activity. Breakdown of laminin in the vascular basement membrane may be a cause of loss of vascular integrity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2245163      PMCID: PMC1971527          DOI: 10.1038/bjc.1990.366

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  28 in total

1.  Lymphoid tissue- and inflammation-specific endothelial cell differentiation defined by monoclonal antibodies.

Authors:  A M Duijvestijn; M Kerkhove; R F Bargatze; E C Butcher
Journal:  J Immunol       Date:  1987-02-01       Impact factor: 5.422

2.  Augmentation of antitumor efficacy by the combination of recombinant tumor necrosis factor and chemotherapeutic agents in vivo.

Authors:  J A Krosnick; J J Mulé; J K McIntosh; S A Rosenberg
Journal:  Cancer Res       Date:  1989-07-15       Impact factor: 12.701

3.  Viscous resistance to blood flow in solid tumors: effect of hematocrit on intratumor blood viscosity.

Authors:  E M Sevick; R K Jain
Journal:  Cancer Res       Date:  1989-07-01       Impact factor: 12.701

4.  Combination immunotherapy of cancer in a mouse model: synergism between tumor necrosis factor and other defense systems.

Authors:  M Chun; M K Hoffmann
Journal:  Cancer Res       Date:  1987-01-01       Impact factor: 12.701

5.  Effects of tumor necrosis factor (TNF) on transplanted tumors induced by methylcholanthrene in mice. A histopathologic study.

Authors:  T Kawai; N Satomi; N Sato; A Sakurai; K Haranaka; T Goto; M Suzuki
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1987

6.  Studies on the anti-tumor efficacy of systemically administered recombinant tumor necrosis factor against several murine tumors in vivo.

Authors:  A Asher; J J Mulé; C M Reichert; E Shiloni; S A Rosenberg
Journal:  J Immunol       Date:  1987-02-01       Impact factor: 5.422

7.  Macroscopic and microscopic early effects of tumour necrosis factor on murine Meth A sarcoma, and relation to curative activity.

Authors:  P A Van de Wiel; N Bloksma; C F Kuper; F M Hofhuis; J M Willers
Journal:  J Pathol       Date:  1989-01       Impact factor: 7.996

8.  The relationship between regional variations in blood flow and histology in a transplanted rat fibrosarcoma.

Authors:  G M Tozer; S Lewis; A Michalowski; V Aber
Journal:  Br J Cancer       Date:  1990-02       Impact factor: 7.640

9.  Tumor necrosis factor/cachectin-induced intravascular fibrin formation in meth A fibrosarcomas.

Authors:  P Nawroth; D Handley; G Matsueda; R De Waal; H Gerlach; D Blohm; D Stern
Journal:  J Exp Med       Date:  1988-08-01       Impact factor: 14.307

10.  The effects of melphalan and misonidazole on the vasculature of a murine sarcoma.

Authors:  J C Murray; V Randhawa; J Denekamp
Journal:  Br J Cancer       Date:  1987-03       Impact factor: 7.640

View more
  4 in total

1.  Intracarotid recombinant human tumor necrosis factor-alpha reduces cerebral blood flow and methionine uptake in rat brain tumors.

Authors:  T Sasajima; K Mineura; M Kowada; J Hatazawa; S Miura
Journal:  J Neurooncol       Date:  1997-09       Impact factor: 4.130

2.  Influence of recombinant tumour necrosis factor alpha on blood flow and antibody localisation in human tumour xenografts in nude mice.

Authors:  M V Pimm; S J Gribben; T M Morris
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

3.  Positron emission tomographic assessment of cerebral hemocirculation and glucose metabolism in malignant glioma following treatment with intracarotid recombinant human tumor necrosis factor-alpha.

Authors:  T Sasajima; K Mineura; J Sasaki; M Kowada; N Tomura; J Hatazawa; T Ogawa; K Uemura
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

4.  Effect of tumour necrosis factor on the uptake of specific and control monoclonal antibodies in a human tumour xenograft model.

Authors:  G Rowlinson-Busza; A Maraveyas; A A Epenetos
Journal:  Br J Cancer       Date:  1995-04       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.